Use of dipeptidyl peptidase-4 inhibitors and new-onset rheumatoid arthritis in patients with type 2 diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L. Use of dipeptidyl peptidase-4 inhibitors and new-onset rheumatoid arthritis in patients with type 2 diabetes. Epidemiology 2018 Nov;29(6):904-912.

View All Publications